Recent CSL Limited (ASX: CSL) News

a woman
⏸️ Investing

Why QBE is up 24% in one month

It looks as though things may finally be looking up for the insurer and its shareholders.

Read more »

a woman
⏸️ Investing

More share trades, but no more profits

Number of trades rises 32% but average value of each one falls 11%.

Read more »

a woman
⏸️ Investing

ASX stocks to benefit from falling Aussie dollar

With the Aussie dollar dipping below parity with the US dollar, several stocks are set to benefit

Read more »

a woman
⏸️ Investing

Fortescue, CSL among those benefitting from a weaker AUD

Who else is getting a boost from the rate cut?

Read more »

⏸️ Investing

Will Primary Health Care raise its dividend?

Investors are hoping to see at least a 30% rise.

Read more »

⏸️ Investing

ASX Hot Stocks: Seven West, CSL and Dyesol

ASX posts strong rise of 1.1% - one of these stocks rose more than 100%

Read more »

a woman
⏸️ Investing

QBE a loser from interest rate cut

Retailers like Myer and David Jones may benefit from the cut, but insurers and banks could take a hit.

Read more »

⏸️ Investing

3 ASX stocks that beat the market today

ASX ends flat, after initial surge on the back of local bank results

Read more »

a woman
⏸️ Investing

CSL wins contracts

The company is also getting back into influenza vaccines.

Read more »

a woman
⏸️ Investing

CSL hits all time highs

Can our largest pharmaceuticals company justify its share price?

Read more »

a woman
⏸️ Investing

Real-life Monopoly lessons

How to win the game and real life

Read more »

a woman
⏸️ Investing

All eyes on CSL now

Recent reports of avian flu in China have put the spotlight back on this vaccine developer.

Read more »

⏸️ Investing

10 stocks driving the ASX 200

Despite a dip in the index experienced in May last year, investors have welcomed the 15% ascent of the S&P/ASX…

Read more »

a woman
⏸️ Investing

Abbott: Medibank Private to go under the hammer

Sale could raise around $4 billion.

Read more »

⏸️ Investing

AMP, CSL and Macquarie dumped

ASX ends flat, but investors drop three of our largest companies

Read more »

⏸️ Investing

The ASX stock that beat Buffett

Since 1999, this stock outperformed Berkshire 1,996% to 102%.

Read more »

⏸️ Investing

Amcor packs rise in profits

But 2013 financial year earnings expected to be inline with previous year

Read more »

⏸️ Investing

Ansell's growth slows

Top-line growth can't make up for increasing costs.

Read more »

a woman
⏸️ Investing

The 'Aussie' most overvalued

Australian dollar estimated to be 60% overvalued

Read more »

a woman
⏸️ Investing

CSL's healthy result

CSL maintains forecast for 24% earnings growth

Read more »

a woman
⏸️ Investing

Investors drown out Cochlear

Market takes dislike to $77.7m half year profit announcement

Read more »

⏸️ Investing

The death of buy-and-hold investing has been greatly exaggerated

ASX performance over last two years is proof

Read more »

a woman
⏸️ Investing

Where to for the Aussie dollar?

Should the currency be headed down, now is the time to look at foreign investments

Read more »

⏸️ Investing

Digging for buried treasure

5 mid-cap companies worthy of further research

Read more »

a woman
⏸️ Investing

The Motley Fool's Test XI

Our picks for the Australian team

Read more »

a woman
⏸️ Investing

White paper: Our future is Asia

Businesses need to work hand-in-hand with governments

Read more »

⏸️ Investing

Cochlear suffers first 'strike'

30% of shareholders vote down remuneration report

Read more »

⏸️ Investing

CSL: An Aussie success story

CSL is outperforming the market and expanding its reach

Read more »

a woman
⏸️ Investing

I'm not too big to admit I was wrong

The ASX 200 hovers near a 14-month high, but one leading analyst thinks shares could be set to soar remarkably…

Read more »

a woman
⏸️ Investing

Healthcare: The next China boom?

Australian companies set to benefit

Read more »

a woman
⏸️ Investing

Invest better: 21 invaluable investing quotes

Today is Worldwide Invest Better Day and The Motley Fool is reacquainting investors with the basic building blocks of investing.

Read more »

⏸️ Investing

Aussie dollar set to fall

Downward pressure continues to build

Read more »

⏸️ Investing

Starpharma still reaching for the sky

Growth continues for this biotech hopeful

Read more »

a woman
⏸️ Investing

Another Australian company winning on the world stage

World beating company delivers again, but is it cheap enough to buy?

Read more »

a woman
⏸️ Investing

Hits and misses as the ASX closes flat

ASX closes marginally down, as ex-dividend stocks take their toll

Read more »

⏸️ Investing

Greying population is gold for investors

An ageing population and rising healthcare costs are good news for these companies

Read more »

⏸️ Investing

Abnormal items take a toll

Mixed results from mining related companies, while RBA leaves rates on hold

Read more »

⏸️ Investing

Profit falls never sound good

Unhappy investors punish Cochlear's share price

Read more »

a woman
⏸️ Investing

Action-seeking investors punish market

BHP's writedowns and Healthcare stocks in the news

Read more »

⏸️ Investing

Resmed reports 12% jump in profit

Could this be a stock to watch?

Read more »